Monographie - Cefiderocol sulfate tosylate

Viimeisin päivitys :
19/11/2024

Cefiderocol sulfate tosylate

Kemiallinen rakenne

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fetcroja

Espanja, Iso-Britannia, Italia, Meksiko, Ranska, Ruotsi, Saksa, Suomi

Viitteet : Cefiderocol sulfate tosylate

	tyyppi	julkaisu
2093	Laboratorio	Cefiderocol (Fetcroja®)- Summary of Product Characteristics Shionogi B.V. 2020
4528	Lehti	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4634	Lehti	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4801	Lehti	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales